<!DOCTYPE HTML>
<html>
  <head>
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8">
    <title>Monitoring, Referrals and Warnings</title>
	</head>
  <body onLoad="init();">
    <div data-role="page" data-theme="a">
  	<div data-role="header" data-theme="b" data-position="inline">
    	<h1>Monitoring, Referrals and Warnings</h1> 
    	<a href="#" data-rel="back" data-icon="arrow-l" data-direction="reverse" >Back</a>
	</div>
    <div data-role="content">
  <p><b>Monitoring, Referrals and Warnings:</b> Monitor for the development of diabetes, hyperglycemia. Monitor vital signs, lipid profile, BMI, fasting glucose at baseline, weight gain, bp, mental status, orthostatic bp, abnormal involuntary movements, extrapyramidal symptoms.</p>
	<p>May impair the mental or physical abilities required for the performance of hazardous tasks such as driving a car. Warn the patient accordingly. May elevate prolactin levels, monitor appropriately. Advise patient of the possibility of orthostatic hypotension especially during the initial dose titration.</p> 
	<p>Monitor for NMS and immediately discontinue antipsychotics if signs and symptoms of NMS occur. Symptoms include hyperpyrexia, muscle rigidity, altered mental status (including catatonic signs) and evidence of autonomic instability (irregular pulse or bp, tachycardia, diaphoresis and cardiac arrhythmias). The chances of NMS occurring in second generation antipsychotics is less than in the first generation antipsychotics.</p> 
	<p>May be used as augmentation to antidepressants by specialty clinics in patients with treatment resistant depression.</p>
    </div><!-- end jqm content -->
   
    </div><!-- end jqm page -->
  </body>
</html>
